β¨ Medicines Consent Notices
1 MAY 2014 NEW ZEALAND GAZETTE, No. 44 1291
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Isuprel
Active Ingredient: Isoprenaline hydrochloride 200mcg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturers:
- Abbott Laboratories Srl, Latina, Italy
- Hospira SpA, Milano, Italy
- Hospira Inc, Kansas, United States of America
Dated this 24th day of April 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2595
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Escitalopram
Active Ingredient: Escitalopram oxalate 6.388mg equivalent to Escitalopram 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Air Flow Products Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Product: Escitalopram
Active Ingredient: Escitalopram oxalate 12.776mg equivalent to Escitalopram 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Air Flow Products Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Product: Escitalopram
Active Ingredient: Escitalopram oxalate 25.552mg equivalent to Escitalopram 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Air Flow Products Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Product: Montelukast Actavis 4
Active Ingredient: Montelukast sodium 4.16mg equivalent to Montelukast 4mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Product: Montelukast Actavis 5
Active Ingredient: Montelukast sodium 5.2mg equivalent to Montelukast 5mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Product: Montelukast Actavis 10
Active Ingredient: Montelukast sodium 10.4mg equivalent to Montelukast 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a New Medicine - Isuprel
π₯ Health & Social Welfare24 April 2014
Medicines, Distribution, Isuprel, Isoprenaline hydrochloride, Hospira NZ Limited
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines - Escitalopram and Montelukast
π₯ Health & Social Welfare24 April 2014
Medicines, Distribution, Escitalopram, Montelukast, Air Flow Products Limited, Actavis New Zealand Limited
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2014, No 44